Frazzoni M - Search Results

1

Characteristics of gastro-esophageal reflux episodes in Barrett's esophagus, erosive esophagitis and healthy volunteers.

Savarino E, Zentilin P, Frazzoni M, Cuoco DL, Pohl D, Dulbecco P, Marabotto E, Sammito G, Gemignani L, Tutuian R, Savarino V. Savarino E, et al. Among authors: frazzoni m. Neurogastroenterol Motil. 2010 Oct;22(10):1061-e280. doi: 10.1111/j.1365-2982.2010.01536.x. Epub 2010 Jun 17. Neurogastroenterol Motil. 2010. PMID: 20557468

2

Lansoprazole vs. omeprazole for gastro-oesophageal reflux disease: a pH-metric comparison.

Frazzoni M, De Micheli E, Grisendi A, Savarino V. Frazzoni M, et al. Aliment Pharmacol Ther. 2002 Jan;16(1):35-9. doi: 10.1046/j.1365-2036.2002.01138.x. Aliment Pharmacol Ther. 2002. PMID: 11856076 Free article. Clinical Trial.

3

Hiatal hernia is the key factor determining the lansoprazole dosage required for effective intra-oesophageal acid suppression.

Frazzoni M, De Micheli E, Grisendi A, Savarino V. Frazzoni M, et al. Aliment Pharmacol Ther. 2002 May;16(5):881-6. doi: 10.1046/j.1365-2036.2002.01248.x. Aliment Pharmacol Ther. 2002. PMID: 11966495 Free article. Clinical Trial.

4

Effective intra-oesophageal acid suppression in patients with gastro-oesophageal reflux disease: lansoprazole vs. pantoprazole.

Frazzoni M, De Micheli E, Grisendi A, Savarino V. Frazzoni M, et al. Aliment Pharmacol Ther. 2003 Jan;17(2):235-41. doi: 10.1046/j.1365-2036.2003.01405.x. Aliment Pharmacol Ther. 2003. PMID: 12534408 Free article. Clinical Trial.

5

Different patterns of oesophageal acid exposure distinguish complicated reflux disease from either erosive reflux oesophagitis or non-erosive reflux disease.

Frazzoni M, De Micheli E, Savarino V. Frazzoni M, et al. Aliment Pharmacol Ther. 2003 Dec;18(11-12):1091-8. doi: 10.1046/j.1365-2036.2003.01768.x. Aliment Pharmacol Ther. 2003. PMID: 14653828 Free article.

6

Pathophysiological characteristics of patients with non-erosive reflux disease differ from those of patients with functional heartburn.

Frazzoni M, De Micheli E, Zentilin P, Savarino V. Frazzoni M, et al. Aliment Pharmacol Ther. 2004 Jul 1;20(1):81-8. doi: 10.1111/j.1365-2036.2004.01998.x. Aliment Pharmacol Ther. 2004. PMID: 15225174 Free article. Clinical Trial.

7

Intra-oesophageal acid suppression in complicated gastro-oesophageal reflux disease: esomeprazole versus lansoprazole.

Frazzoni M, Manno M, De Micheli E, Savarino V. Frazzoni M, et al. Dig Liver Dis. 2006 Feb;38(2):85-90. doi: 10.1016/j.dld.2005.10.001. Epub 2005 Nov 10. Dig Liver Dis. 2006. PMID: 16289976 Clinical Trial.

8

Pathophysiological characteristics of the various forms of gastro-oesophageal reflux disease. Spectrum disease or distinct phenotypic presentations?

Frazzoni M, Manno M, De Micheli E, Savarino V. Frazzoni M, et al. Dig Liver Dis. 2006 Sep;38(9):643-8. doi: 10.1016/j.dld.2006.02.020. Epub 2006 Apr 14. Dig Liver Dis. 2006. PMID: 16627016

9

Efficacy in intra-oesophageal acid suppression may decrease after 2-year continuous treatment with proton pump inhibitors.

Frazzoni M, Manno M, De Micheli E, Savarino V. Frazzoni M, et al. Dig Liver Dis. 2007 May;39(5):415-21. doi: 10.1016/j.dld.2007.01.023. Epub 2007 Mar 26. Dig Liver Dis. 2007. PMID: 17379591 Clinical Trial.

10

The role of nonacid reflux in NERD: lessons learned from impedance-pH monitoring in 150 patients off therapy.

Savarino E, Zentilin P, Tutuian R, Pohl D, Casa DD, Frazzoni M, Cestari R, Savarino V. Savarino E, et al. Among authors: frazzoni m. Am J Gastroenterol. 2008 Nov;103(11):2685-93. doi: 10.1111/j.1572-0241.2008.02119.x. Epub 2008 Sep 4. Am J Gastroenterol. 2008. PMID: 18775017

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

118 results

Search Page

Filters